The World Health Organization (WHO) has approved Sinovac Covid-19 vaccine for emergency use in order to meet the global shortage.
The vaccine now becomes the eight vaccine in the world by the world health governing body and will also be included under the COVAX facility to help poor nations.
It is also the second Chinese based vaccine approved by WHO behind Sinopharm that was approved a month ago.
- DR Congo: lava from volcano eruption hits Goma airport
- Missing Bobi Wine’s bodyguard Daniel Apedel found dead
- China: Tornado kills eight in Wuhan, injures hundreds
Speaking on the new development was Mariangela Simao who said that the world currently needs a number of vaccines to meet the shortage across the globe for an effective health product.
WHO Director-General Tedros Adhanom Ghebreyesus also confirmed the new entry of Sinovac Covid-19 vaccine as game changer and a solution to the gap between the rich and poor countries.
He continued by expressing how happy he was with the news confirming that the vaccine is tested as effective to fight the virus.
Production of the new vaccine incorporates the introduction of a virus that will trigger the body to produce antibodies to fight it effectively.
During its series of tests, the Chinese based company inoculated a number of adults and the results revealed a 95% drop in new infection and 85% drop in deaths related to the virus.